Memorial Sloan Kettering Cancer Center
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D
- First Posted Date
- 2013-04-16
- Last Posted Date
- 2020-08-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT01833143
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
πΊπΈMemorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States
Breath Training Exercise for the Reduction of Chronic Dyspnea
- Conditions
- Chronic Pulmonary Disorder
- Interventions
- Other: breathing techniquesBehavioral: Self-Administered Baseline and Transition Dyspnea Indexes
- First Posted Date
- 2013-04-15
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT01831388
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer
- Conditions
- Rectal Cancer
- Interventions
- Procedure: Advanced MR Imaging
- First Posted Date
- 2013-04-12
- Last Posted Date
- 2017-06-22
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 28
- Registration Number
- NCT01830582
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers
- Conditions
- Breast Cancer
- Interventions
- Other: Verbal and Written InstructionOther: Verbal and Written Plus Simulation
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2015-09-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 51
- Registration Number
- NCT01829984
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
- Conditions
- Diffuse Large B-cell Lymphoma (DLBCL)Non Hodgkin Lymphoma (NHL)
- Interventions
- First Posted Date
- 2013-04-11
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 201
- Registration Number
- NCT01829958
- Locations
- πΊπΈ
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
πΊπΈMemorial Sloan Kettering Bergen, Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma
- Conditions
- Advanced Biliary Tract Carcinoma
- Interventions
- First Posted Date
- 2013-04-10
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 42
- Registration Number
- NCT01828034
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer
- Conditions
- HER2-Positive Early Stage Breast Cancer
- Interventions
- First Posted Date
- 2013-04-09
- Last Posted Date
- 2019-12-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT01827163
- Locations
- πΊπΈ
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan-Kettering Cancer Commack, Commack, New York, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States
Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
- Conditions
- Primary PeritonealOvarian CancerFallopian Tube
- Interventions
- Procedure: Positron Emission TomographyRadiation: 18F-Fluoro-2-deoxy-D-lucoseProcedure: Cytoreductive surgery
- First Posted Date
- 2013-04-08
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT01826227
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
- Conditions
- Appendix CancerColorectal Cancer
- Interventions
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 292
- Registration Number
- NCT01815359
- Locations
- πΊπΈ
University of Miami, Miami, Florida, United States
πΊπΈMemorial Sloan Kettering Bergen (Consent and Follow up), Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Westchester (Consent and Follow up), Harrison, New York, United States
A Registry for Patients Treated on the Clinical Trial TAX 3503
- Conditions
- Prostate Cancer
- Interventions
- Other: No intervention
- First Posted Date
- 2013-03-19
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 52
- Registration Number
- NCT01813370
- Locations
- π±πΉ
Klaipeda University Hospital, Klaipeda, Lithuania
πΊπΈJohn Hopkins Medical Center, Baltimore, Maryland, United States
πΊπΈMemorial Sloan Kettering Cancer Center, New York, New York, United States